Intangible Assets (Tables)

3 Months Ended

Sep. 30, 2020

Disclosure Intangible Assets Tables Abstract

Schedule of Intangible Assets

The Company’s intangible assets consist of intellectual property acquired from LAT Pharma, Inc. and are amortized over their estimated useful lives. The following is a summary of the intangible assets as of September 30, 2020 and June 30, 2020:

	September 30, 2020			June 30, 2020
Intellectual Property	$	2,293,770		$	2,293,770
Less Accumulated Amortization		(1,025,888	)		(968,544	)
Intellectual Property, Net	$	1,267,882		$	1,325,226

Schedule of Future expected Amortization of intangible assets

Amortization expense for the three-month period ended September 30, 2020 and 2019 was $57,344 and $57,344 respectively.

Estimated future amortization expense is as follows:

Year ending June 30, 2021 (Remaining nine months)	$                         172,032
2022	229,377
2023	229,377
2024	229,377
2025	229,377
2026	178,342
	$                      1,267,882